Monte Rosa Therapeutics Inc (GLUE) Financials

$14.07

$-0.25 (-1.75%)

As on 11-Sep-2026 16:00EDT

Market cap

$1,181 Mln

Revenue (TTM)

$29 Mln

P/E Ratio

--

P/B Ratio

2.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	28.73	123.67	75.62	--	--	--
Cost of Revenue	6.21	8.36	8.12	6.22	8.56	2.13
Gross Profit	26.70	115.32	67.50	-6.22	-8.56	-2.13
Operating Expenses	208.55	169.52	148.61	137.09	112.38	72.88
Operating Profit (EBIT)	-181.85	-54.21	-81.11	-143.31	-112.38	-72.88
Other Income	--	--	--	--	0.12	-1.12
Profit before Tax	-163.97	-39.72	-70.13	-135.01	-108.50	-73.96
Provision for Tax	-2.86	-1.10	2.57	0.34	-3.88	-2.02
Profit after Tax (Net Income)	-161.12	-38.63	-72.70	-135.35	-108.50	-73.96
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-108.50	-73.96

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	487.28	233.06	222.94	179.25	271.41	347.52
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	144.22	151.39	58.85	77.91	45.41	2.18
Current Liabilities	66.81	64.21	156.95	46.59	25.57	16.64
Total Liabilities	765.12	448.66	438.73	303.76	342.39	366.33

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	59.76	55.47	61.29	67.54	66.50	17.66
Current Assets	636.33	393.19	377.44	236.21	275.89	348.67
Total Assets	760.66	448.66	438.73	303.76	342.39	366.33
Total Debt*	37.99	39.19	42.72	46.04	47.00	--
Net Current Assets	571.75	328.97	220.49	189.62	250.32	332.03

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-22.80	42.00	-43.80	-92.47	-59.36
Cash Flow from Investing Activities	--	-101.83	-44.45	88.80	-219.22	-9.65
Cash from Financing Activities	--	30.35	98.89	27.49	20.47	377.56
Net Cash Inflow / Outflow	--	--	--	--	-291.22	308.55

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.18	-0.59	-1.18	-2.38	-2.22	-1.61
Cash EPS ($)	--	-0.46	-1.05	-2.28	-2.14	-1.56
Adjusted Book Value ($)	--	3.56	3.63	3.15	5.55	7.56
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.35	0.68	-0.77	-1.89	-1.29
Free Cash Flow per Share ($)	--	-0.42	0.62	-1.10	-2.16	-1.50

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-14.36	-29.62	-49.79	-32.59	-40.35
ROE (%)	-44.73	-16.94	-36.15	-60.07	-35.06	-49.51
ROA (%)	-27.73	-8.71	-19.58	-41.90	-30.62	-35.58
EBIT Margin (%)	-570.80	-32.12	-92.74	--	--	--
Net Margin (%)	-560.85	-31.23	-96.14	--	-91,177.31	6,591.62
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-83.86	0.64	--	--	--	--
EBIT Growth (%)	-676.89	43.36	48.06	-28.91	-41.62	-164.04
Net Profit Growth (%)	-766.65	46.87	46.29	-24.75	-46.71	-106.13
EPS Growth (%)	-841.83	0.50	0.50	-0.07	-0.38	0.03
Book Value Growth (%)	31.63	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-26.61	-5.86	-2.38	-3.43	-12.70
Price / Book Value	2.52	4.41	1.91	1.79	1.37	2.70
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	51.86	-21.99	-1.56	-1.05	-1.55	-8.26
Close Price ($)	24.20	15.68	6.94	5.65	7.61	20.42
High Price ($)	25.77	19.17	12.40	8.83	21.56	45.56
Low Price ($)	4.12	3.50	3.21	2.44	6.05	15.67
Market Cap ($ Cr)	1,180.74	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.17	0.19	0.26	0.17	--
Short term debt to equity ratio	0.01	0.02	0.02	0.02	0.01	--
Current Ratio	9.52	6.12	2.40	5.07	10.79	20.96
Quick Ratio	9.52	--	--	--	10.75	--
Interest Coverage	--	--	--	--	-27.83	-68.73

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	34.25	3.72	0.23	--	--	--
Asset Turnover	0.05	0.28	0.20	--	--	--
Receivable days	--	7.05	1.64	--	--	--
Inventory Days	--	--	--	56.35	40.97	--
Payable days	--	453.83	637.92	558.09	307.68	1,167.02
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.